BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4625288)

  • 1. The pharmacology of the antimalarial drug 4,4'-diformamidodiphenylsulfone (DFD) in dog and monkey.
    Sonntag AC; Stenger VG; Vogh BP; Maren TH
    J Pharmacol Exp Ther; 1972 Jul; 182(1):34-47. PubMed ID: 4625288
    [No Abstract]   [Full Text] [Related]  

  • 2. 4,4'-diformamidodiphenylsulfone (DFD): analysis of plasma and urine for unsubstituted arylamine in the presence of metabolites and acid-labile substituents on the parent compound.
    Vogh BP; Garg LC; Sonntag AC; Maren TH
    Clin Chim Acta; 1972 Sep; 40(2):431-42. PubMed ID: 5056142
    [No Abstract]   [Full Text] [Related]  

  • 3. Repository drugs. V. 4',4'''-[p-phenylenebis(methylidyneimino-p-phenylenesulfonyl)]bisacetanilide (PSBA) and related 4',4'''-[bis(imino-p-phenylenesulfonyl)]bisanilides, a novel class of long-acting antimalarial and antileprotic agents.
    Elslager EF; Phillips AA; Worth DF
    J Med Chem; 1969 May; 12(3):363-7. PubMed ID: 4977944
    [No Abstract]   [Full Text] [Related]  

  • 4. Action of 4,4'-diformamidodiphenylsulfone (DFD) and related compounds on Plasmodium berghei.
    Vogh BP; Gleason LN
    J Pharmacol Exp Ther; 1971 Apr; 177(1):301-8. PubMed ID: 5566771
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of the sulfones.
    Bushby SR
    Int J Lepr Other Mycobact Dis; 1967; 35(4):572-9. PubMed ID: 5626305
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary studies on the anti-malarial activity of SDDS (2-sulfamoyl-4, 4'-diaminodiphenylsulfone) against Plasmodium berghei and Plasmodium gallinaceum.
    Ishii A; Sasa M; Chinzei H; Oshima S; Tanaka H
    Jpn J Exp Med; 1967 Aug; 37(4):301-21. PubMed ID: 5301401
    [No Abstract]   [Full Text] [Related]  

  • 7. Further experience with the kinetic method for the study of drugs against Mycobacterium leprae in mice. Activities of DDS, DFD, ethionamide, capreomycin and PAM 1392.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1969; 37(4):389-97. PubMed ID: 4918202
    [No Abstract]   [Full Text] [Related]  

  • 8. The repository antimalarial activities of 4,4'-diacetylaminodiphenylsulfone and cycloguanil pamoate (Cl-501) in monkeys relative to local release following parenteral administration.
    Thompson PE; Waitz JA; Olszewski B
    J Parasitol; 1965 Jun; 51(3):345-9. PubMed ID: 4953989
    [No Abstract]   [Full Text] [Related]  

  • 9. An improved pharmacodynamic model for formation of methemoglobin by antimalarial drugs.
    Fasanmade AA; Jusko WJ
    Drug Metab Dispos; 1995 May; 23(5):573-6. PubMed ID: 7587933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repository antimalarial drugs: N,N'-diacetyl-4,4'-diaminodiphenylsulphone and related 4-acylaminodiphenylsulphones.
    Elslager EF; Worth DF
    Nature; 1965 May; 206(984):630-1. PubMed ID: 4953605
    [No Abstract]   [Full Text] [Related]  

  • 11. [Toxicology of synthetic aminoquinoleic antimalarials].
    Fauran F; Sankale M
    Therapie; 1970; 25(4):823-50. PubMed ID: 4989869
    [No Abstract]   [Full Text] [Related]  

  • 12. Deformylation of 4,4'-diformamidodiphenyl sulfone (DFD) by mammalian liver homogenates.
    Chiou CY
    Biochem Pharmacol; 1971 Sep; 20(9):2401-8. PubMed ID: 5163151
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimalarial studies on 4,4-diaminodiphenyl sulfone (DDS) and repository sulfones in experimental animals.
    Thompson PE
    Int J Lepr Other Mycobact Dis; 1967; 35(4):605-15. PubMed ID: 5626306
    [No Abstract]   [Full Text] [Related]  

  • 14. The metabolism of N-(3-chlorobenzenesulphonyl) acetamidine in the dog and rat.
    Faulkner JK; Stopher DA
    Xenobiotica; 1972 Mar; 2(2):179-89. PubMed ID: 4560366
    [No Abstract]   [Full Text] [Related]  

  • 15. Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.
    Edstein MD; Kotecka BM; Anderson KL; Pombo DJ; Kyle DE; Rieckmann KH; Good MF
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4421-2. PubMed ID: 16189139
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
    Marino MT; Peggins JO; Brown LD; Urquhart MR; Brewer TG
    Drug Metab Dispos; 1994; 22(3):358-66. PubMed ID: 8070311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-dependent hydrolysis of 4,4'-diformamidodiphenylsulfone.
    Garg LC
    J Pharm Sci; 1971 Apr; 60(4):606-8. PubMed ID: 5128374
    [No Abstract]   [Full Text] [Related]  

  • 18. A new analytical procedure for dapsone. Application to blood-level and urinary-excretion studies in normal men.
    Glazko AJ; Dill WA; Montalbo RG; Holmes EL
    Am J Trop Med Hyg; 1968 May; 17(3):465-73. PubMed ID: 5652701
    [No Abstract]   [Full Text] [Related]  

  • 19. Deformylation of 4,4'-diformamidodiphenyl sulfone (DFD) by plasma of certain mammals.
    Gleason LN; Vogh BP
    Biochem Pharmacol; 1971 Sep; 20(9):2409-16. PubMed ID: 5163152
    [No Abstract]   [Full Text] [Related]  

  • 20. Chloroquine and dihydroquinine. In vitro studies by their antimalarial effect upon Plasmodium knowlesi.
    Polet H; Barr CF
    J Pharmacol Exp Ther; 1968 Dec; 164(2):380-6. PubMed ID: 4972437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.